Inicio Eventos Jornadas Jornadas de Largos Supervivientes en Cáncer de Pulmón

Jornadas de Largos Supervivientes en Cáncer de Pulmón

Name: Jornada Multidisciplinar en el manejo de los pacientes con CPNM
Start: 2026-02-27
End: 2026-02-27
Location: Hotel Monumento San Francisco

Tendrá lugar en Santiago de Compostela.

Coordinación

Dr. Sergio Vázquez – Hospital Universitario Lucus Augusti
Dra. Karmele Areses – Complejo Hospitalario Universitario de Ourense

¿Qué hemos aprendido? Experiencia proyecto HERMES

Dr. Sergio Vazquez – Complejo Hospitalario Lucus Augusti

Consenso Largo Superviviente

Dra. Karmele Areses – Complejo Hospitalario Universitario de Ourense.

Discusión y consenso

El evento está terminado.

Tags:Largos Supervivientes en Cáncer de Pulmón

Fecha

24 Sep 2025

¡Caducado!

Hora

17:00

Más Información

Programa

Localización

Finca da Rocha

Santiago de Compostela

Localización 2

Santiago de Compostela

Categoría

Jornadas

Programa

Oradores

Dr. Sergio Vázquez

Dr. Sergio Vázquez
Karmele Areses

Karmele Areses

Cookie	Duración	Descripción
_GRECAPTCHA	5 months 27 days	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duración	Descripción
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_EPVF5VTN8Y	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_222472387_3	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.

Cookie	Duración	Descripción
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt.innertube::nextId	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.

Jornadas de Largos Supervivientes en Cáncer de Pulmón

Coordinación

¿Qué hemos aprendido? Experiencia proyecto HERMES

Consenso Largo Superviviente

Discusión y consenso

El evento está terminado.

Fecha

Hora

Más Información

Localización

Localización 2

Oradores

Real-world clinical experience of the Galician Lung Cancer Group: Afatinib in patients with EGFR positive mutation.

Galician lung cancer group: Afatinib’s data as first-line treatment for elderly patients.

Utility of the Lung Inmune Prognostic Index (LIPI) in prognostication and disease control prediction in advanced NSCLC patients treated with nivolumab.

Third and successive-lines of chemotherapy in NSCLC patientes without therapeutic targets: Experience of the Grupo Gallego de Cáncer de Pulmón.

Efficacy and safety of Crizotinib in patient with ALK positive non small cell lung cancer (NSCLC): Real-world findings.

Jornadas de Largos Supervivientes en Cáncer de Pulmón

Coordinación

¿Qué hemos aprendido? Experiencia proyecto HERMES

Consenso Largo Superviviente

Discusión y consenso

El evento está terminado.

Fecha

Hora

Más Información

Localización

Localización 2

Oradores

Compartir este evento

Eventos relacionados

IV JORNADAS MULTIDISCIPLINARIAS DE ACTUALIZACIÓN EN CÁNCER DE PULMÓN. XIV REUNIÓN ANUAL DEL GRUPO GALLEGO DE CÁNCER DE PULMÓN ¡Caducado!

V Jornadas Multidisciplinares de Actualización en Cáncer de Pulmón. XVI Reunión Anual del GGCP ¡Caducado!

VI JORNADAS MULTIDISCIPLINARES DE CÁNCER DE PULMÓN. XIX Reunión anual del Grupo Gallego de Cáncer de Pulmón. ¡Caducado!

I JORNADA GALAICO PORTUGUESA DE CANCRO DE PULMÃO. Revisión postASCO y controversias ¡Caducado!

Real-world clinical experience of the Galician Lung Cancer Group: Afatinib in patients with EGFR positive mutation.

Galician lung cancer group: Afatinib’s data as first-line treatment for elderly patients.

Utility of the Lung Inmune Prognostic Index (LIPI) in prognostication and disease control prediction in advanced NSCLC patients treated with nivolumab.

Third and successive-lines of chemotherapy in NSCLC patientes without therapeutic targets: Experience of the Grupo Gallego de Cáncer de Pulmón.

Efficacy and safety of Crizotinib in patient with ALK positive non small cell lung cancer (NSCLC): Real-world findings.